• Return to Headlines

Recent 52-Week High Exceeded in Shares of Exact Sciences (EXAS)

By James Quinn

Shares of Exact Sciences (NASDAQ:EXAS) traded at a new 52-week high today of $117.18. This new high was reached on below average trading volume as 120,000 shares traded hands, while the average 30-day volume is approximately 1.8 million shares.

Exact Sciences Corporation, a molecular diagnostics company, focuses on developing products for the early detection and prevention of various cancers in the United States.

Over the past year, Exact Sciences has traded in a range of $47.78 to $117.18 and is now at $117.18, 145% above that low. In the last five trading sessions, the 50-day moving average (MA) has climbed 1.3% while the 200-day MA has risen 0.7%.

Exact Sciences (NASDAQ:EXAS) defies analysts with a current price ($117.18) 50.1% above its average consensus price target of $58.45. The stock should discover initial support at its 50-day moving average (MA) of $99.47 and subsequent support at its 200-day MA of $82.74.

SmarTrend recommended that subscribers consider buying shares of Exact Sciences on May 16th, 2019 as our proprietary SmarTrend analytics indicated a new Uptrend was in progress when shares hit $97.67. Since that recommendation, shares of Exact Sciences have risen 18.5%. We continue to monitor EXAS for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.

Keywords: 52 week high/lows exact sciences

Ticker(s): EXAS